Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1994
|
| gptkbp:ATCCode |
R03BA05
|
| gptkbp:brand |
gptkb:Flovent_Diskus
gptkb:Flovent_HFA |
| gptkbp:contraindication |
hypersensitivity to fluticasone
|
| gptkbp:drugClass |
gptkb:Corticosteroid
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:form |
aerosol
inhaler 110 mcg 220 mcg 44 mcg |
| gptkbp:genericName |
gptkb:fluticasone_propionate
|
| https://www.w3.org/2000/01/rdf-schema#label |
Flovent
|
| gptkbp:legalStatus |
Rx-only (US)
|
| gptkbp:manufacturer |
GlaxoSmithKline
|
| gptkbp:mechanismOfAction |
reduces inflammation in airways
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
oral thrush
hoarseness throat irritation |
| gptkbp:storage |
room temperature
|
| gptkbp:usedFor |
asthma
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:GSK
gptkb:fluticasone gptkb:Metered_Dose_Inhaler |
| gptkbp:bfsLayer |
6
|